Related Experiment Video
Updated: Aug 12, 2026
06:32
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Selecting the components for a safe and efficient tuberculosis subunit vaccine--recent progress and post-genomic
Limei Meng Okkels1, T Mark Doherty, Peter Andersen
1Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark.
Current Pharmaceutical Biotechnology
|February 7, 2003
Summary
New genomics, proteomics, and transcriptomics approaches accelerate the discovery of novel tuberculosis (TB) vaccine candidates. These advanced methods are crucial for developing improved vaccines beyond BCG to combat the resurgence of TB globally.
Area of Science:
- Immunology and Vaccinology
- Genomics, Proteomics, and Transcriptomics
- Infectious Diseases
Background:
- Bacille Calmette-Guérin (BCG) vaccination was historically significant in reducing tuberculosis (TB) incidence in Europe.
- Resurgent TB rates worldwide necessitate the development of more effective vaccines.
- Existing vaccine strategies require enhancement to address current global health challenges.
Purpose of the Study:
- To review advancements in genomics, proteomics, and transcriptomics for TB vaccine antigen discovery.
- To highlight novel approaches for accelerating TB vaccine development.
- To identify promising new vaccine candidates and targets for tuberculosis.
Main Methods:
- Leveraging genomics to identify potential TB antigens.
- Utilizing proteomics to analyze protein targets for vaccine development.
- Employing transcriptomics to understand host-pathogen interactions and identify antigens.
- Integrating computational biology with molecular biology techniques.
Main Results:
- Genomics, proteomics, and transcriptomics have significantly accelerated the identification of candidate TB vaccine antigens.
- These multi-omics approaches enable a more rational and rapid vaccine discovery pipeline.
- Several promising new vaccine candidates and molecular targets have emerged from these studies.
Conclusions:
- Modern omics technologies are transforming tuberculosis vaccine research and development.
- A rapid, rational approach to antigen discovery is key to improving upon current BCG vaccines.
- Continued application of these advanced methodologies holds significant promise for developing next-generation TB vaccines.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...